Sermonix Pharmaceuticals
Sermonix Pharmaceuticals is a privately held biotechnology company based in Columbus, OH, specializing in the development and commercialization of female-specific oncology products. Founded in 2014 by Dr. David Portman, a renowned clinical researcher and women's health expert, Sermonix Pharmaceuticals focuses on advancing treatments for breast and ovarian cancer, with a particular emphasis on the study of lasofoxifene.
The company is currently conducting the ELAINE Study, an open-label, randomized, multicenter trial that evaluates the efficacy of lasofoxifene compared to fulvestrant in the treatment of postmenopausal and premenopausal women with locally advanced or metastatic estrogen receptor-positive (ER+), human epidermal growth factor 2-negative (HER2-) breast cancer. Sermonix Pharmaceuticals is dedicated to providing innovative solutions for women's oncology and is actively involved in clinical research and collaborations with industry partners.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.





